CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-09 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −35,598 | $110.61 | $3.9M | 77,896 |
| 2023-01-09 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −4,538 | $111.73 | $507K | 73,358 |
| 2023-01-09 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −3,940 | $112.78 | $444K | 69,418 |
| 2023-01-09 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −38,216 | $113.78 | $4.3M | 31,202 |
| 2023-01-09 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Sale | −1,702 | $114.46 | $195K | 29,500 |
| 2023-01-09 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Option exercise · Stock Option (Right to Buy) | −83,994 | 0 | ||
| 2022-12-30 | WENDELL PETER C Director | Grant or award · Phantom Stock | +270.39 | $110.95 | $30K | 117,421.08 |
| 2022-12-30 | Seidman Christine E Director | Grant or award · Phantom Stock | +73.23 | $110.95 | $8K | 10,192.68 |
| 2022-12-30 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +405.59 | $110.95 | $45K | 86,420.41 |
| 2022-12-30 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +292.92 | $110.95 | $32K | 17,083.92 |
| 2022-12-19 | Romanelli Joseph President, Human Health Int?l | Purchase | +7 | $109.04 | $763 | 20,484.33 |
| 2022-12-13 | Romanelli Joseph President, Human Health Int?l | Purchase | +56 | $110.96 | $6K | 20,477.33 |
| 2022-12-06 | Romanelli Joseph President, Human Health Int?l | Purchase | +30 | $109.39 | $3K | 20,421.33 |
| 2022-12-05 | Romanelli Joseph President, Human Health Int?l | Purchase | +107 | $109.54 | $12K | 20,391.33 |
| 2022-12-02 | Romanelli Joseph President, Human Health Int?l | Purchase | +59 | $109.67 | $6K | 59 |
| 2022-11-10 | MIZELL STEVEN EVP, Chief HR Officer | Option exercise | +15,000 | 47,144.15 | ||
| 2022-11-10 | MIZELL STEVEN EVP, Chief HR Officer | Sale | −15,000 | $101.42 | $1.5M | 32,144.15 |
| 2022-11-10 | MIZELL STEVEN EVP, Chief HR Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 824 | ||
| 2022-11-09 | Oosthuizen Johannes Jacobus President, U.S. Market | Sale | −1,795 | $103.21 | $185K | 16,730.88 |
| 2022-11-09 | Davis Robert M CEO & President | Option exercise | +167,613 | 415,205.76 |
Page 28 of 29 · 572 trades